jueves, 7 de noviembre de 2024

Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab George Bertsias,Jinoos Yazdany

https://www.thelancet.com/journals/lanrhe/issue/vol6no11/PIIS2665-9913(24)X0011-9

No hay comentarios:

Publicar un comentario